RBC Capital raised the firm’s price target on Tenet Healthcare to $136 from $109 and keeps an Outperform rating on the shares. The firm cites the company’s Q1 earnings while also noting its potential for core outperformance this year on strong demand, acuity, and evolving payor mix trends, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
Questions or Comments about the article? Write to editor@tipranks.com